Physiology and Clinical Utility of HeartMate Pump Parameters
- PMID: 34980564
- PMCID: PMC9106934
- DOI: 10.1016/j.cardfail.2021.11.016
Physiology and Clinical Utility of HeartMate Pump Parameters
Abstract
The HeartMate 3 left ventricular assist device (LVAD) is now the only centrifugal pump intended for durable support being actively manufactured and implanted for adults in the United States. The changes in preload and afterload that accompany common clinical scenarios experienced by patients with an LVAD will cause specific changes to the LVAD pump parameters, namely, the pump power, pulsatility index, and flow. Appropriate care of this unique, and growing, population requires a full understanding of these variables as well as the underlying physiologic principles governing their derivation. The aim of this review is to focus on the updated functionality of the HeartMate 3, specifically in comparison to the HeartMate II, as well as the application of pump parameter interpretation to common clinical scenarios.
Keywords: HeartMate; Left ventricular assist device; pulsatility index; pump parameters.
Copyright © 2021 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.J Thorac Cardiovasc Surg. 2020 Jul;160(1):132-139.e1. doi: 10.1016/j.jtcvs.2019.09.151. Epub 2019 Oct 16. J Thorac Cardiovasc Surg. 2020. PMID: 31740114 Free PMC article.
-
Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device.Trends Cardiovasc Med. 2020 May;30(4):223-229. doi: 10.1016/j.tcm.2019.05.013. Epub 2019 Jun 4. Trends Cardiovasc Med. 2020. PMID: 31201005 Review.
-
Use of left ventricular assist device (HeartMate II): a Singapore experience.Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7. Artif Organs. 2014. PMID: 24392937
-
Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030. Ann Thorac Surg. 2008. PMID: 18805167
-
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.J Heart Lung Transplant. 2016 Apr;35(4):528-36. doi: 10.1016/j.healun.2016.01.021. Epub 2016 Jan 30. J Heart Lung Transplant. 2016. PMID: 27044532 Review.
Cited by
-
Successful management of HeartMate 3 in a patient with arrhythmogenic right ventricular cardiomyopathy.J Artif Organs. 2024 Feb 24. doi: 10.1007/s10047-024-01434-2. Online ahead of print. J Artif Organs. 2024. PMID: 38396198
-
Aortic valve disorders and left ventricular assist devices.Front Cardiovasc Med. 2023 Feb 23;10:1098348. doi: 10.3389/fcvm.2023.1098348. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36910539 Free PMC article. Review.
-
A Holistic View of Advanced Heart Failure.Life (Basel). 2022 Aug 24;12(9):1298. doi: 10.3390/life12091298. Life (Basel). 2022. PMID: 36143336 Free PMC article. Review.
References
-
- Miller LW. Left ventricular assist devices are underutilized. Circulation 2011;123:1552–8. - PubMed
-
- Truby LK, Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. JACC Heart Fail 2020;8:523–36. - PubMed
-
- Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019;38:1056–66. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
